Chronic idiopathic urticaria with functional autoantibodies: 12 years on. (Q36458515)

14 August 2017

1 reference

title

Chronic idiopathic urticaria with functional autoantibodies: 12 years on. (English)

1 reference

14 August 2017

1 reference

1 reference

1 reference

2

Greaves MW

1 reference

14 August 2017

Sabroe RA

1

1 reference

PubMed ID

16634880

14 August 2017

language of work or name

English

0 references

publication date

1 May 2006

1 reference

British Journal of Dermatology

14 August 2017

1 reference

14 August 2017

154

1 reference

14 August 2017

5

1 reference

14 August 2017

813-819

1 reference

Chronic urticaria: pathogenesis and treatment

14 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

Classification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

High prevalence of autoimmune urticaria in children with chronic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

IL3 effect on basophils histamine release upon stimulation with chronic urticaria sera.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

Assessment of histamine-releasing activity of sera from patients with chronic urticaria showing positive autologous skin test on human basophils and mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

Inhibition of Cytokine Gene Transcription by the Human Recombinant Histamine-Releasing Factor in Human T Lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

Evidence for aberrant regulation of the p21Ras pathway in PBMCs of patients with chronic idiopathic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

A bispecific antibody against human IgE and human FcgammaRII that inhibits antigen-induced histamine release by human mast cells and basophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

Conditional autoimmunity mediated by human natural anti-Fc(epsilon)RIalpha autoantibodies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

Defining criteria for autoimmune diseases (Witebsky's postulates revisited)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

Plasmapheresis for severe, unremitting, chronic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

Thyroid autoimmunity in chronic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

Improvement of chronic idiopathic urticaria with L-thyroxine: a new TSH role in immune response?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

The impact of chronic urticaria on the quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

The extent and nature of disability in different urticarial conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

The autologous serum skin test in the follow-up of patients with chronic urticaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

Multiple NSAID intolerance in chronic idiopathic urticaria is correlated with delayed, pronounced and prolonged autoreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

Sera from patients with multiple drug allergy syndrome contain circulating histamine-releasing factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

The relationship between Helicobacter pylori IgG antibody and autologous serum test in chronic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

Mechanisms of autoimmune activation of basophils in chronic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

Reducing disparities in asthma care: priorities for research--National Heart, Lung, and Blood Institute workshop report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

Basophil CD63 expression assay on highly sensitized atopic donor leucocytes-a useful method in chronic autoimmune urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

Chronic urticaria: aetiology, management and current and future treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

Definition, classification, and routine diagnosis of urticaria: a consensus report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

Fexofenadine's effects, alone and with alcohol, on actual driving and psychomotor performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

Effects of calcineurin inhibitors on an in vitro assay for chronic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

Tacrolimus in the treatment of severe chronic idiopathic urticaria: an open-label prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

Methotrexate-responsive chronic idiopathic urticaria: a report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

Chronic idiopathic urticaria: Comparison of the clinical features of patients with and without anti-FcϵRI or anti-IgE autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07183.X

10.1111/J.1365-2133.2006.07183.X

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16634880